Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Ovarian Neoplasms
×
Histamine Antagonists
×
Clear all
Filters
3
NCT06824467
2026-03-13
TroFuse-022
Merck Sharp & Dohme LLC
Phase 3
Recruiting
770 enrolled